Skip to main content
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

Abortion Pill Case Goes To Supreme Court


The lengths Big Pharma, Democrats and their loyal liberal servants will go to continue the wholesale murder of unborn babies is truly disturbing.

If the young woman can’t get a procedure, they’ll give her a pill that will have devasting effects on her and kill the baby as well.

It’s pretty gruesome. Like really bad.

I won’t go into the details in this article, but I’ll just say there are plenty of women who have used the abortion pill procedure and deeply regret it and the traumatic experience that occured to them shortly afterwards.

And so the Supreme Court will be hearing the case for and against this deeply disturbing pill next Tuesday.

Breitbart reports:

The Supreme Court is set to hear oral arguments on Tuesday, March 26, in a case that could have a significant impact on how mifepristone — the first drug used in a two-drug medication abortion regimen — is used and prescribed in the United States.

The case, FDA v. Alliance for Hippocratic Medicine, surrounds the U.S. Food and Drug Administration’s (FDA) rolling back of safety restrictions for mifepristone, including its 2016 action extending the permissible gestational age of the baby for which a girl or woman may take abortion drugs from seven weeks gestation to ten weeks gestation and its 2021 rule change allowing abortionists to send mifepristone through the mail. The FDA also recently made permanent its rule to allow women and girls to receive a prescription for mifepristone via telemedicine.

The Alliance Defending Freedom (ADF) filed the lawsuit in November of 2022 against the FDA on behalf of four national medical associations and several doctors, alleging the agency “chose politics over science and approved chemical abortion drugs for use in the United States.”

“The U.S. Food and Drug Administration (FDA) — the federal agency responsible for ensuring the safety of drugs that Americans take — has betrayed women and girls,” Erik Baptist, senior counsel with the ADF and co-counsel on the case, said during a press conference in Washington, DC, on Thursday.

“Women should have the ongoing care of a doctor when taking high risk drugs. But in recent years, the FDA has recklessly removed nearly every safeguard the agency previously considered necessary for abortion drugs, including in-person doctor visits to check for ectopic pregnancies, severe bleeding, and life-threatening infections,” Baptist added. “Without question, the FDA’s actions made taking high-risk abortion drugs less safe for women.”

Justices agreed to take up the case in December of 2023. In September, both President Joe Biden’s Department of Justice (DOJ) and Danco Laboratories LLC, which distributes mifepristone under the brand name Mifeprex, asked the Supreme Court to reverse a lower court decision halting two FDA actions that loosened restrictions on the abortion pill. The Supreme Court ultimately granted a hearing to both cases, consolidating them into one with a total of one hour allotted for oral argument.

Biden’s DOJ and Danco Laboratories appealed an August ruling from the U.S. Court of Fifth Circuit, which found that the FDA’s 2016 decision to allow the abortion pill to be taken up to ten weeks of pregnancy instead of seven weeks is unlawful. The court said the same of the FDA’s 2021 rule change, which allowed the abortion pill to be mailed directly to patients and allowed medical professionals other than doctors to prescribe mifepristone.

“In loosening mifepristone’s safety restrictions, FDA failed to address several important concerns about whether the drug would be safe for the women who use it,” reads the panel opinion, penned by Judge Jennifer Walker Elrod.

“It failed to consider the cumulative effect of removing several important safeguards at the same time. It failed to consider whether those ‘major’ and ‘interrelated’ changes might alter the risk profile, such that the agency should continue to mandate reporting of non-fatal adverse events,” the opinion continued. “And it failed to gather evidence that affirmatively showed that mifepristone could be used safely without being prescribed and dispensed in person.”

Elrod wrote that at the preliminary stage, plaintiffs “have made a substantial showing” that the 2016 and 2021 rule changes violate the Administrative Procedure Act (APA).

Despite the Fifth Circuit’s ruling against the government and the drug manufacturer, mifepristone has remained available under existing regulations while the litigation continues. The Supreme Court preemptively paused any ruling from an appeals court this spring, pending a petition for the Supreme Court to take the case.

The ADF’s lawsuit points to six discrete agency actions since the legalization of mifepristone and misoprostol in 2000. The ADF alleges that the agency was only able to approve the drug by falsely classifying pregnancy as an “illness.” The lawsuit also alleges that the FDA never studied the safety of mifepristone under the labeled conditions of use, ignored the potential impacts of the hormone-blocking regimen on the developing bodies of adolescent girls, disregarded evidence that chemical abortion drugs cause more complications than surgical abortion, and eliminated necessary safeguards for pregnant girls and women who take the regimen.

The lawsuit details how, in 2016, the FDA extended the permissible gestational age for which a girl or woman may take the abortion drugs. Then, in 2021, the FDA allowed abortionists to send mifepristone through the mail, which the ADF says was “in direct violation of federal law.”

This killer drug is taken in 2 doses.

Luckily this doctor belows mentions that if a women changes her mind after the 1st dose, there is the ability to PREVENT the babies death.

Reversing the procedure is possible.

Pray that this pill is eradicated from existence.



 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Leave a comment
Thanks for sharing!